Insider Trades24 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | Sell | LXRX | Suma Gopinathan | SVP, Discovery | 24,338 | $1.47 | $889.9M | -25.37% | +88.68% | $35.8K | -7.46% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Rachel Yap Martens | SVP, Partnerships & Corp Strat | 35,826 | $1.47 | $889.9M | -25.37% | +88.68% | $52.7K | -17.80% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Scott M Coiante | SVP, Chief Financial Officer | 54,881 | $1.47 | $889.9M | -25.37% | +88.68% | $80.7K | -11.42% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Wendy Mcdermott | SVP, Human Resources | 68,107 | $1.47 | $889.9M | -25.37% | +88.68% | $100.1K | -9.91% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Lisa Defrancesco | SVP, IR and Corp Comm | 74,572 | $1.47 | $889.9M | -25.37% | +88.68% | $109.6K | -16.59% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Brian T Crum | SVP, General Counsel & Secr. | 105,019 | $1.47 | $889.9M | -25.37% | +88.68% | $154.4K | -11.13% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Craig B Granowitz | SVP, Chief Medical Officer | 109,098 | $1.47 | $889.9M | -25.37% | +88.68% | $160.4K | -11.97% | — | Buy Now |
| Feb 28, 2026 | Sell | LXRX | Michael Exton | Chief Executive Officer | 204,831 | $1.47 | $889.9M | -25.37% | +88.68% | $301.1K | -13.57% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Lisa Defrancesco | SVP, IR and Corp Comm | 9,096 | $0.67 | $889.9M | -25.37% | +88.68% | $6.1K | -12.29% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Kristen Alexander | VP, Finance and Accounting | 17,862 | $0.67 | $889.9M | -25.37% | +88.68% | $12.0K | -11.91% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Wendy Mcdermott | SVP, Human Resources | 30,004 | $0.67 | $889.9M | -25.37% | +88.68% | $20.1K | -10.57% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Alan J Main | EVP, Innov & Chem Sciences | 43,434 | $0.67 | $889.9M | -25.37% | +88.68% | $29.1K | -7.87% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Brian T Crum | SVP, General Counsel & Secr. | 45,622 | $0.67 | $889.9M | -25.37% | +88.68% | $30.6K | -9.53% | — | Buy Now |
| Feb 28, 2025 | Sell | LXRX | Craig B Granowitz | SVP, Chief Medical Officer | 65,308 | $0.67 | $889.9M | -25.37% | +88.68% | $43.8K | -17.66% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Kristen Alexander | VP, Finance and Accounting | 11,793 | $2.62 | $889.9M | -25.37% | +88.68% | $30.9K | -11.55% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Wendy Mcdermott | VP, Human Resources | 22,425 | $2.62 | $889.9M | -25.37% | +88.68% | $58.8K | -15.00% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Kenneth B. Kassler-Taub | SVP, Regulatory & QA | 24,353 | $2.62 | $889.9M | -25.37% | +88.68% | $63.8K | -8.69% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Alan J Main | EVP, Innov & Chem Sciences | 24,408 | $2.62 | $889.9M | -25.37% | +88.68% | $63.9K | -6.57% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Brian T Crum | SVP, General Counsel & Secr. | 25,604 | $2.62 | $889.9M | -25.37% | +88.68% | $67.1K | -8.65% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Craig B Granowitz | SVP, Chief Medical Officer | 31,265 | $2.62 | $889.9M | -25.37% | +88.68% | $81.9K | -17.53% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Jeffrey L Wade | President and CFO | 37,691 | $2.62 | $889.9M | -25.37% | +88.68% | $98.8K | -7.58% | — | Buy Now |
| Feb 28, 2024 | Sell | LXRX | Lonnel Coats | Chief Executive Officer | 61,371 | $2.62 | $889.9M | -25.37% | +88.68% | $160.8K | -4.11% | — | Buy Now |
| Nov 16, 2023 | Buy | LXRX | Lonnel Coats | Chief Executive Officer | 90,000 | $1.05 | $889.9M | -25.37% | +88.68% | $94.8K | +10.92% | — | Buy Now |
| Nov 10, 2023 | Buy | LXRX | Lonnel Coats | Chief Executive Officer | 10,000 | $1.01 | $889.9M | -25.37% | +88.68% | $10.1K | +1.23% | — | Buy Now |